Regulatory Pathways and Market Access for MedTech

Government and regulatory affairs counsel Beata Spuhler presented in a session titled “Regulatory Pathways and Market Access for MedTech” at the MedTech Forum 2026. The session focused on the practical realities of US market access, from regulatory pathways and approval processes to postmarket requirements, as well as the broader policy developments influencing these frameworks. Bringing together industry and policy experts as well as regulators, the session highlighted the regulatory and market shifts companies need to anticipate, and how the landscape may evolve in the years ahead.